About Tytex
Tytex is a company based in Ikast (Denmark) founded in 1996 was acquired by Zefyr in August 2019. Tytex offers products and services including Post-op Bra, Medical Fixation Device, and Incontinence Garment. Tytex operates in a competitive market with competitors including Axonics, Averto Medical, Boomerang Medical, Signum Surgical and NovoGI, among others.
- Latest Funding Round$613.13 (USD), Grant
Aug 2023
- InvestorsJacob Holm
& 2 more
- Acquired by
Products & Services of Tytex
Tytex offers a comprehensive portfolio of products and services, including Post-op Bra, Medical Fixation Device, and Incontinence Garment.
Garment designed for post-surgical recovery and support.
Device for securing dressings and promoting healing.
Garment providing support for incontinence management.
Apps and channels of Tytex
its YouTube channel Tytex has 8 subscribers.
Funding Insights of Tytex
- Total Rounds 6
- Last Round Grant — $613
- First Round $230,464
(Sep 2020)
- Investors Count 1
All 6 funding rounds of Tytex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $613 | Grant | – | – | |
| Jun 2023 | $623 | Grant | – | – | |
| Apr 2023 | $1,229 | Grant | – | – | |
| Mar 2023 | $1,222 | Grant | – | – | |
| Mar 2023 | $331 | Grant | – | – | |
| Sep 2020 | $230,464 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Tytex
Tytex has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Jacob Holm, slovensko.sk and Zefyr Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | slovensko.sk | - | |
Investments in niche B2B companies are managed by Zefyr Invest. | – | zefyrinvest.dk | Esbjerg, Denmark | |
Manufacturer of medical textiles and wound care products | 1794 | jacob-holm.com | Basel, Switzerland |
Investor details for Tytex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tytex
1 people are tracked at Tytex (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jan Dam | Co-Owner & CEO | Leadership |
Complete people profiles for Tytex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Tytex
5 dated milestones of Tytex across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Tytex is founded.
- Exit Acquired by Jacob Holm.
- Exit Acquired by Zefyr.
- Funding First funding round of $230K.
- Funding Latest funding round, Grant, of $613.
Competitors of Tytex
Tytex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Averto Medical, Boomerang Medical, Signum Surgical and NovoGI, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| axonics.com | 2013 | Irvine, United States | $143.47M | 762 | Sacral neuromodulation devices are developed for urinary and bowel control. | |
| avertomed.com | 2016 | Fremont, United States | $33M | 18 | Medical devices for gastrointestinal disease patients are developed. | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | – | Bioelectronic devices are developed for autoimmune disease treatment. | |
| signumsurgical.com | 2014 | Galway, Ireland | $5.73M | – | Surgically implanted devices for perianal fistula treatment are provided. | |
| novogi.com | 1996 | Netanya, Israel | $18.5M | – | Provides compression anastomosis devices for GI disease management. | |
| mowoot.com | 2014 | Barcelona, Spain | $3.98M | – | A non-invasive medical device for chronic constipation treatment is developed. | |
| spirusmedllc.com | 2005 | West Bridgewater, United States | $15.24M | – | Spiral over-tubes and steerable introducers for GI endoscopy are provided. | |
| exeromedical.com | 2018 | Or Yehuda, Israel | $10M | – | Develoepr of a sensor device for early detection of anastomotic leaks | |
| colospan.com | 2010 | Kfar Saba, Israel | $8M | – | Intraluminal bypass devices are developed to reduce colorectal surgery complications. |
Detailed competitors of Tytex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Tytex
Websites that share an audience with Tytex (tytex.com).
Websites whose visitors overlap most with Tytex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| attends.co.uk | 89% | 6.9K | #2,960,624 | View details |
Latest news on Tytex
Complete news archive for Tytex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Tytex
10 companies that operate in the same segment as Tytex (Gastroenterology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | – | 533 | |
Developer of electrosurgical system and range of flexible endoscopic instruments | 2003 | Chepstow, Monmouthshire, United Kingdom | USD 20.84 M | USD 8.08 M | 141 | |
Non-invasive biomarker tests for colorectal cancer are developed. | 2015 | St. Louis, Missouri, United States | USD 218.95 M | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | 2009 | Ramat Gan, Tel Aviv District, Israel | USD 13.5 M | USD 288.27 K | 35 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tytex
Tytex was founded in 1996 and raised its 1st funding round 24 years after it was founded.
Tytex is headquartered in Ikast, Denmark.
Jan Dam is the current CEO of Tytex.
Tytex was founded in 1996 in Ikast, Denmark, and operates in the healthcare sector by manufacturing medical apparels. Products are designed for urinary and fecal incontinence management, post-surgery support and compression, ostomy care, hernia prevention, wound dressings, IV fixation, hip protection, and maternity lingerie for pregnancy and nursing. Focus remains on practical solutions for patient recovery and daily care needs.
Tytex's top competitors include Axonics, Signum Surgical and Exero Medical.
Tytex offers Post-op Bra, Medical Fixation Device, and Incontinence Garment.
Tytex has 3 investors. Key investors include Jacob Holm, slovensko.sk, and Zefyr Invest.
Tytex operates through Tytex A/S.
Yes. Tytex was acquired by Zefyr in August 2019.